• Bengaluru
  • 7 May 2015
  • News
  • By Ayesha

'We will launch a new product soon'

After spinning off its seed business, Camson Bio Technologies will now focus more on its biocides, bio-fertilizers business, Mr Santosh Nair, CEO, Camson Bio Technologies told BioSpectrum


Mr Santosh Nair, CEO, Camson Bio Technologies

Camson Bio Technologies, an agri-biotech company focused on biocides, biofertilizers and hybrid seeds, has demerged its business into two separate entities, Camson BioTech Limited (CBTL) and Camson Seeds Limited.

The Camson Seeds will soon be listed in the stock market. "We have already completed 95 percent of the process. We have received approval from all the concerned authorities, only RoC from income tax department is remaining, which we will get it in a month and hopefully by June, it should legally be a separate entity," said Mr Santosh Nair, CEO, Camson Bio Technologies, speaking exclusively to BioSpectrum.

The shareholding pattern of Camson Seeds will mirror the shareholding pattern of CBTL. Shares will be allotted in the ratio of 1:1 existing shareholders of CBTL will get one equity share of Camson Seeds for every share held in CBTL.

Post demerger, the company will focus more on to its biocides business, which is driving the growth of the company. "Our biocides business has seen good growth over the years and have been driving the company in terms of cash flow. The industry has accepted our products that we started manufacturing. That's why it makes sense to make it a separate vertical and focus more on the business."

The firm will soon launch a new product. "We will launch a new product, Natural Fertilizer, which is one of its kind. A fertilizer purely available in organic form. We are going through the last leg of the trial and test marketing," said Mr Nair. The company has filed patents for the same, both in India and globally.


Previous 1 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email